Nurix Therapeutics Cash from Financing (TTM) Trends

Nurix Therapeutics Inc (NRIX)

12.48 +0.12 (+0.97%) USD | NASDAQ | Apr 26, 13:03

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
February 29, 2024	3.36M
November 30, 2023	3.217M
August 31, 2023	3.075M
May 31, 2023	116.78M
February 28, 2023	117.18M
November 30, 2022	117.19M
August 31, 2022	117.83M

Date	Value
May 31, 2022	3.972M
February 28, 2022	154.01M
November 30, 2021	153.88M
August 31, 2021	152.26M
May 31, 2021	371.12M
February 28, 2021	340.34M
November 30, 2020	339.02M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

3.075M

Minimum

Aug 2023

371.12M

Maximum

May 2021

142.37M

Average

117.51M

Median

Cash from Financing (TTM) Benchmarks